Livopigen ApS: Financial statements 2019
CVR: 37491659
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Livopigen ApS (CVR 37491659) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,183,747 and a net result of DKK 64,840 compared with DKK 27,939 the year before. That is an increase of 30.3% compared with the year before. Equity in the 2019 report amounted to DKK 49,512. The solvency ratio was 3.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,183,747
- Profit/Loss
- DKK 64,840
- Equity
- DKK 49,512
- Total Assets
- DKK 1,439,479
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.2 mio. | 65 t. | 50 t. | 2 |
| 2018 | - | 908 t. | 28 t. | -15 t. | 2 |
| 2017 | - | 539 t. | 227 t. | -43 t. | 2 |
| 2016 | - | 223 t. | -183 t. | -180 t. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Livopigen ApS has published its annual report for 2018. Gross profit came to DKK 908,173, and the net result was DKK 27,939.
About Livopigen ApS
Livopigen ApS was a Danish company of the type Anpartsselskab based in Holbæk, founded in 2016. The company has been dissolved on 11 October 2023. The company was registered under the industry Detailhandel med medicin og produkter til personlig pleje via internet. The company was previously named Genopliv ApS and Genopliv IVS. The company has 2 employees (2022). In 2021, the company reported a gross profit of DKK 1,022,287 and a net result of DKK 42,829 compared with DKK -17,924 the year before. Equity in the 2021 report amounted to DKK 74,417.